iPSC & mESC Lines
iPSC Differentiated Cell
Genome Edited iPSC
Mouse Embryonic Fibroblast (MEF Feeder Cell)
iPSC Generation Kit
Antibody Discovery / Bioproduction
Antibody Screening Library Construction Service
TARGATT™ Master Cell Line HEK293
TARGATT™ Master Cell Line CHO Cells
Antibody in vivo Assay Service
TARGATT™ Rabbit Bioproduction
Applied StemCell Inc. (ASC) is a leading Gene & Cell Therapy CRO company founded on May 8, 2008 and is headquartered in Milpitas, California. Leveraging its more than 12 years of research and development, ASC is proud to support early stage gene and cell therapy development processes with two high impact platforms: CRISPR-TARGATT™ genome editing and stem cell technologies. We are also a member of the National Institute of Technology and Standards (NIST) Genome Editing Consortium where we provide benchmark materials using our unique expertise in stem cell technology and genetic engineering to establish measurements and standards for characterizing genome editing outputs using stem cells.